Autoimmune/infl ammatory syndrome induced by adjuvants, ASIA

Jędrzej Stolarczyk, Marek Kubiś, Marek Brzosko

Abstract


ABSTRACT There have been many cases of the appearance of autoantibodies and symptoms of disease after exposure to adjuvants, not only after breast augmentation with silicone implants, but also as a very rare vaccination side effect, such as Gulf war syndrome or macrophagic myofasciitis syndrome. Diseases whose symptoms developed after such adjuvant exposure are called autoimmune/ inϐlammatory syndrome induced by adjuvants (ASIA). The group of adjuvants includes not only silicone implants, silica, squalen and aluminium, but also ink components used for making tattoos. Analyzing the available reports on the inϐluence of adjuvants on the development of autoimmune diseases, the conclusion is that apart from long -term silicone exposure, the coexistence of other factors such as genetic or environmental is also necessary. Metaanalyses clearly do not conϐirm an increased risk of developing autoimmune disease after breast augmentation with silicone implants, or tattooing, but it seems that among these patients there is a group that is more predestined to develop disease symptoms. In the general population the beneϐits of vaccination are obvious, and the risk of severe adverse events following immunisation is incomparably lower than the risk of developing a speciϐic disease and its complications, also for patients with diagnosed autoimmune diseases. Because of data heterogeneity in previous studies and difϐiculties in diagnosing ASIA it seems necessary to conduct further analyses of adjuvants’ inϐluence on autoimmune disease development, and to reϐine ASIA diagnostic criteria, which now allow too easy a diagnosis of this syndrome.

Keywords


silikon, implant, tatuaż, szczepienie, odpowiedź immunologiczna, choroby autoimmunologiczne

Full Text:

PDF (Język Polski)

References


Agmon -Levin N, Hughes GR, Shoenfeld Y. The spectrum of ASIA: Autoimmune (Auto -inflammatory) Syndrome induced by Adjuvants. Lupus 2012;21(2):118-20.

Shoenfeld Y, Agmon -Levin N. ASIA autoimmune/inflammatory syndrome induced by adjuvants. J Autoimmun 2011;36(1):4-8.

Shoenfeld Y, Maślińska M. Autoimmune (auto -inflammatory) syndrome induced by adjuvants – ASIA. Reumatologia 2013;51(2):101-7.

Brinton LA, Buckley LM, Dvorkina O, Lubin JH, Colton T, Murray MC, et al. Risk of connective tissue disorders among breast implant patients. Am J Epidemiol 2004;160(7):619-27.

Israeli E, Agmon -Levin N, Blank M, Shoenfeld Y. Adjuvants and autoimmunity. Lupus 2009;18(13):1217-25.

Balofsky A, Agmon -Levin N, Shoenfeld Y. The new H1N1 and HPV vaccines and old fears. Curr Opin Rheumatol 2010;22(4):431-6.

Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 2002;347(12):911-20.

Cohen Tervaert JW, Kappel RM. Silicone implant incompatibility syndrome (SIIS): a frequent cause of ASIA (Shoenfeld’s syndrome). Immunol Res 2013;56(2 -3):293-8.

Hajdu SD, Agmon -Levin N, Shoenfeld Y. Silicone and autoimmunity. Eur J Clin Invest 2011;41(2):203-11.

Wolfram D, Oberreiter B, Mayerl C, Soelder E, Ulmer H, Piza -Katzer H. Altered systemic serologic parameters in patients with silicone mammary implants. Immunol Lett 2008;118(1):96-100.

Chruściel J, Leśniak E, Fejdyś M. Karbofunkcyjne silany i polisiloksany.Cz. 2, Otrzymywanie i zastosowania karbofunkcyjnych polisiloksanów. Polimery 2008;53(11 -12):817-29.

Calvert GM, Rice FL, Boiano JM, Sheehy JW, Sanderson WT: Occupational silica exposure and risk of various diseases: an analysis using death certificates from 27 states of the United States. Occup Environ Med 2003;60(2):122-9.

Lippmann M, Eckert HL, Hahon N, Morgan WK. Circulating antinuclear and rheumatoid factors in coal miners. A prevalence study in Pennsylvania and West Virginia. Ann Intern Med 1973;79(6):807-11.

Makol A, Reilly MJ, Rosenman KD. Prevalence of connective tissue disease in silicosis (1985–2006) – a report from the state of Michigan surveillance system for silicosis. Am J Ind Med 2011;54(4):255-62.

Hennekens CH, Lee IM, Cook NR, Hebert PR, Karlson EW, LaMotte F, et al. Self-reported breast implants and connective -tissue diseases in female health professionals. A retrospective cohort study. JAMA

;275(8):616-21.

Janowsky EC, Kupper LL, Hulka BS. Meta-analyses of the relation between silicone breast implants and the risk of connective -tissue diseases. N Engl J Med 2000;342(11):781-90.

Kaiser W, Biesenbach G, Stuby U, Grafinger P, Zazgornik J. Human adjuvant disease: remission of silicone induced autoimmune disease after explanation of breast augmentation. Ann Rheum Dis 1990;49(11):

-8.

Caldeira M, Ferreira AC. Siliconosis: autoimmune/inflammatory syndrome induced by adjuvants (ASIA). Isr Med Assoc J 2012;14(2):137-8.

Pineda JC, Diaz JC, Agualimpia A, Garcia JF. Autoimmune/inflammatory syndrome induced by adjuvants causing myositis and pulmonary fibrosis.

Isr Med Assoc J 2013;15(11):720-1.

Agmon-Levin N, Paz Z, Israeli E, Shoenfeld Y. Vaccines and autoimmunity. Nat Rev Rheumatol 2009;5(11):648-52.

Evans D, Cauchemez S, Hayden FG. “Prepandemic” immunization for novel influenza viruses, “swine flu” vaccine, Guillain–Barré syndrome, and the detection of rare severe adverse events. J Infect Dis 2009;200(3):

-8.

Mikaeloff Y, Caridade G, Suissa S, Tardieu M. Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood. Neurology 2009;72(10):873-80.

Wood RA, Berger M, Dreskin SC, Setse R, Engler RJ, Dekker CL, et al. An algorithm for treatment of patients with hypersensitivity reactions after vaccines. Pediatrics 2008;122(3):e771-7.

Asa PB, Cao Y, Garry RF. Antibodies to squalene in Gulf War syndrome. Exp Mol Pathol 2000;68(1):55-64.

Reddy LH, Couvreur P. Squalene: A natural triterpene for use in disease management and therapy. Adv Drug Deliv Rev 2009;61(15):1412-26.

Carlson KF, Taylor BC, Hagel EM, Cutting A, Kerns R, Sayer NA. Headache diagnoses among Iraq and Afghanistan war veterans enrolled in VA: a gender comparison. Headache 2013;53(10):1573-82.

Gherardi RK, Coquet M, Cherin P, Authier FJ, Laforet P, Belec L, et al. Macrophagic myofasciitis: an emerging entity. Groupe d’Etudes et Recherche sur les Maladies Musculaires Acquises et Dysimmunitaires (GERMMAD) de l’Association Francaise contre les Myopathies (AFM).

Lancet 1998;352:347-52.

Israeli E. Gulf War syndrome as a part of the autoimmune (autoinflammatory) syndrome induced by adjuvant (ASIA). Lupus 2012;21(2):190-4.

Deeken A, Jefferson J, Hawkinson D, Fraga GR. Localized chronic fibrosing vasculitis in a tattoo: a unique adverse tattoo reaction. Am J Dermatopathol

;36(4):e81-3.

Jolly M, Danila MI. Tattoo: inflicted vasculitis? J Clin Rheumatol 2007;13(1):49.

Kazandjieva J, Tsankov N. Tattoos: dermatological complications. Clin Dermatol 2007;25(4):375-82.

Kluger N, Koljonen V. Tattoos, inks, and cancer. Lancet Oncol 2012; 13(4):e161-8.




DOI: https://doi.org/10.21164/pomjlifesci.166

Copyright (c) 2016

License URL: https://creativecommons.org/licenses/by-nc-nd/3.0/pl/